Buys
Open market- Shares
- Avg price
- Total value
Katherine Stueland - CHIEF EXECUTIVE OFFICER, Director at GeneDx Holdings Corp.
Issuer-level insider activity
- Role
- CHIEF EXECUTIVE OFFICER, Director
- Issuer ticker
- WGS, WGSWW on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Katherine Stueland in GeneDx Holdings Corp.
Sells
Open market- Shares
- -154,884
- Avg price
- $85.91
- Total value
- -$13,306,558
Net
Past year- Shares
- -154,884
- Share %
- -100%
- Total value
- -$13,306,558
Reported holdings for Katherine Stueland in GeneDx Holdings Corp.
Form 4 holding
CHIEF EXECUTIVE OFFICER, Director
GeneDx Holdings Corp.
- Security class
- Restricted Stock Unit
- Shares / value
- 56,250
- Estimated value
- $23,210,064
- Report date
- 16 Jun 2026
- Price
- $96.71
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
Form 4 holding
CHIEF EXECUTIVE OFFICER, Director
GeneDx Holdings Corp.
- Security class
- Class A Common Stock
- Shares / value
- 104,372
- Estimated value
- $6,419,243
- Report date
- 16 Jun 2026
- Price
- $61.50
- Ownership
- Direct
Transaction history for Katherine Stueland in GeneDx Holdings Corp.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.